118 related articles for article (PubMed ID: 19765451)
1. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
Ozdemir BH; Bilezikçi B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
[TBL] [Abstract][Full Text] [Related]
3. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
4. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
5. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
6. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
[TBL] [Abstract][Full Text] [Related]
7. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
[TBL] [Abstract][Full Text] [Related]
8. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
[TBL] [Abstract][Full Text] [Related]
10. Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.
Ozdemir BH; Ozdemir FN; Sezer S; Haberal M
Ren Fail; 2007; 29(5):615-22. PubMed ID: 17654326
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
[TBL] [Abstract][Full Text] [Related]
15. Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver.
Fujimiya T; Liu J; Kojima H; Shirafuji S; Kimura H; Fujimiya M
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G451-60. PubMed ID: 19608736
[TBL] [Abstract][Full Text] [Related]
16. Increased iron deposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine.
Guo L; Enzan H; Hayashi Y; Miyazaki E; Jin Y; Toi M; Kuroda N; Hiroi M
Exp Mol Pathol; 2006 Dec; 81(3):255-61. PubMed ID: 16979622
[TBL] [Abstract][Full Text] [Related]
17. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation.
Devi SL; Viswanathan P; Anuradha CV
Eur J Pharmacol; 2010 Nov; 647(1-3):161-70. PubMed ID: 20813107
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cells in biopsies from liver allografts with acute rejection.
Bilezikçi B; Demirhan B; Sar A; Arat Z; Karakayali H; Haberal M
Transplant Proc; 2006 Mar; 38(2):589-93. PubMed ID: 16549182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
